Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Survanta Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The historical period’s growth can be ascribed to several factors, including an increase in premature birth occurrences, heightened understanding of neonatal respiratory distress syndrome, the expansion of neonatal intensive care facilities, better survival outcomes for preterm infants, and the more extensive clinical use of surfactant therapy.
Anticipated growth in the upcoming period is linked to a heightened emphasis on innovative neonatal care technologies, broader availability of neonatal healthcare in developing economies, continuous clinical investigation into therapies for lung maturation, a rising need for early intervention treatments, and enhanced methods for neonatal drug delivery. Concurrently, significant trends expected during this forecast include the expanded application of surfactant replacement therapies, an increased focus on neonatal respiratory care, the global expansion of NICU facilities, advancements in administration techniques for premature infants, and improved standardization of clinical protocols.
Get A Free Sample Report With In-Depth Market Insights:
Survanta Market Growth Backed By Core Demand Fundamentals
The rising occurrence of premature births is a key factor propelling the expansion of the survanta market. Premature births, defined as a baby being born before 37 weeks of gestation, result in underdeveloped organs and heightened health risks. This growing frequency of premature births stems from reasons like advanced maternal age, various lifestyle choices, a rise in chronic health conditions, and progress in fertility treatments. Survanta plays a role in treating respiratory distress syndrome (RDS) in premature infants, a condition frequently seen due to inadequate surfactant in their lungs, thereby enhancing lung function and lowering complication risks. As an example, the Centers for Disease Control and Prevention, a US government agency, reported that the preterm birth rate was 10.41% in 2024, as noted in April 2025. Consequently, the rising incidence of premature births is fueling the expansion of the survanta market. Future growth in the survanta market is anticipated to be driven by rising investments in maternal and child health. This area encompasses the welfare of women throughout pregnancy, birth, and the postpartum phase, alongside the health and development of children, especially in their early years. Growing financial commitments in maternal and child health are motivated by goals to decrease maternal and infant mortality, enhance access to healthcare, and foster enduring social and economic progress. Such investments facilitate access to crucial treatments like survanta, thereby lowering neonatal deaths caused by respiratory distress syndrome. For example, in September 2024, the American Hospital Association, a US professional body, stated that the Department of Health and Human Services committed over $558 million (USD 0.558) to maternal health programs, with $440 million (USD 0.44) designated for home visiting services and $118.5 million (USD 0.1185) for CDC initiatives. Consequently, increased funding in maternal and child health is boosting the survanta market’s growth.
Survanta Market Segment Analysis: What Are The Core Market Categories?
The survanta market covered in this report is segmented –
1) By Indication: Respiratory Distress Syndrome (RDS), Meconium Aspiration Syndrome (MAS), Bronchopulmonary Dysplasia (BPD), Acute Respiratory Failure, Other Indications
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Public Health Clinics
3) By End-User: Pediatric
Survanta Market Top Companies Driving Competitive Growth
Major companies operating in the survanta market are AbbVie Ltd.
View The Full Survanta Market Report:
Survanta Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the survanta market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the survanta market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
